GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2022 Results Conference Call March 29, 2023 8:30 AM ET Company Participants Christian Dinneen-Long - General Counsel and Company Secretary Harout Semerjian - Chief Executive Officer Brian Hahn - Chief Financial Officer Edwin Rock - Chief Medical Officer Conference Call Participants Roger Song - Jefferies Operator Good morning. And thank you for joining the GlycoMimetics Fourth Quarter and Full Year 2022 Earnings Call. At this time, all participants are in a listen only m ...